04 August 2026
NeutroTarget – Blood-Based Immune Biomarker for prognosis, prediction and monitoring of Immunotherapy Response and in Breast Cancer
A new blood-based immune biomarker to stratify and monitor cancer patients to reduce ineffective immunotherapy use.
(more…)
